Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Mont-Saint-Guibert, Belgium, March 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the fourth quarter and full year 2022. Recent Financial and Operating Highlights Completed all 115 implants in the [...]










